Esperion Therapeutics (ESPR) Goodwill & Intangibles (2012 - 2026)
Esperion Therapeutics (ESPR) posted Goodwill & Intangibles of $56000.0 for Q1 2026, little changed on a QoQ basis from $56000.0 in Q4 2025, and little changed year-over-year from $56000.0 in Q1 2025.
Esperion Therapeutics (ESPR) Goodwill & Intangibles (2012 - 2026) Analysis & Trends
Esperion Therapeutics' Goodwill & Intangibles history runs 15 years deep, the most recent figure standing at $56000.0 for Q1 2026.
- Quarterly Goodwill & Intangibles changed 0.0% year-over-year to $56000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $56000.0 (changed 0.0% YoY) and the FY2025 annual result came in at $56000.0, changed 0.0% from the prior year.
- Goodwill & Intangibles was $56000.0 for Q1 2026 at Esperion Therapeutics, roughly flat from $56000.0 in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at $56000.0 in Q1 2022 and bottomed at $56000.0 in Q1 2022.
- A 5-year average of $56000.0 and a median of $56000.0 in 2022 frame the typical range for Goodwill & Intangibles.
- Peak annual rise in Goodwill & Intangibles reached 0.0% in 2022, while the deepest fall reached 0.0% in 2022.
- Esperion Therapeutics' Goodwill & Intangibles stood at $56000.0 in 2022, then changed by 0.0% to $56000.0 in 2023, then changed by 0.0% to $56000.0 in 2024, then changed by 0.0% to $56000.0 in 2025, then changed by 0.0% to $56000.0 in 2026.
- Business Quant data shows ESPR's Goodwill & Intangibles at $56000.0 in Q1 2026, $56000.0 in Q4 2025, and $56000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Esperion Therapeutics | 799.30 Mn | 643.14 Mn | 45.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 56,000.00 |
| Dec 31, 2025 | 56,000.00 |
| Sep 30, 2025 | 56,000.00 |
| Jun 30, 2025 | 56,000.00 |
| Mar 31, 2025 | 56,000.00 |
| Dec 31, 2024 | 56,000.00 |
| Sep 30, 2024 | 56,000.00 |
| Jun 30, 2024 | 56,000.00 |
| Mar 31, 2024 | 56,000.00 |
| Dec 31, 2023 | 56,000.00 |
| Sep 30, 2023 | 56,000.00 |
| Jun 30, 2023 | 56,000.00 |
| Mar 31, 2023 | 56,000.00 |
| Dec 31, 2022 | 56,000.00 |
| Sep 30, 2022 | 56,000.00 |
| Jun 30, 2022 | 56,000.00 |
| Mar 31, 2022 | 56,000.00 |
| Dec 31, 2021 | 56,000.00 |
| Sep 30, 2021 | 56,000.00 |
| Jun 30, 2021 | 56,000.00 |